# Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking

> **NCT00183222** · PHASE2 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 160 (—)

## Conditions studied

- Alcohol Dependence

## Interventions

- **DRUG:** naltrexone (up to 50 mg/day) for 8 days; ondansetron (0.25 mg twice a day) for 8 days

## Key facts

- **NCT ID:** NCT00183222
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 160 (—)
- **Last updated:** 2010-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00183222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00183222, "Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00183222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*